Direct evidence of the role of autophagy in controlling NAFLD comes from the studies of Wang et al. (104) who developed three potent agonists for Transcription Factor EB (TFEB), a master regulator of lysosomal biogenesis and autophagy. The gene discussed is TFEB; the disease is metabolic dysfunction-associated steatotic liver disease.